What Are the Side Effects of Gabapentin 300 mg?

Gabapentin at 300 mg is one of the most commonly prescribed starting doses, and its side effects tend to be milder than those seen at higher doses, but they are far from negligible. Drowsiness, dizziness, and fatigue top the list, with swelling in the lower legs, weight gain, and cognitive fog following close behind. At this dose, most people tolerate the drug reasonably well, but the side-effect profile shifts depending on your age, kidney function, other medications, and how long you stay on it. What looks like a mild drug at 300 mg can behave quite differently in certain bodies and combinations.

The Everyday Side Effects Most People Notice First

The side effects you are most likely to encounter at 300 mg are the ones your nervous system feels immediately: drowsiness, dizziness, and a general sense of unsteadiness. These show up because gabapentin reduces the activity of certain calcium channels in the nervous system, which dials down nerve signaling more broadly than just in the pain or seizure pathways it targets.¹ That dampening effect is what makes it useful for nerve pain, but it also explains why you might feel mentally sluggish or physically wobbly, especially in the first week or two.

Nausea is another common early complaint. A study comparing different dosing schedules found that splitting the same total daily dose into smaller, more frequent portions reduced dizziness, unsteadiness, sleepiness, and nausea during the initial two-week titration period.² This is partly why many prescribers start at 300 mg once daily at bedtime rather than three times a day: the sedation becomes a feature instead of a bug, helping with sleep while you adjust to the drug.

For most people, these acute effects ease up within the first couple of weeks as the brain adapts. If they persist or feel disabling, it usually means the dose is climbing too fast or your body clears the drug more slowly than average.

Swelling and Weight Gain

Peripheral edema, the puffy swelling that shows up in your ankles and lower legs, is one of the more distinctive gabapentin side effects. Most of the data on this comes from older patients taking doses above 1,200 mg per day, where the rate runs around 7 to 7.5 percent. But case reports have documented the same swelling at doses as low as 300 mg twice daily, even in younger patients.³ If you notice your shoes getting tighter or your socks leaving deep impressions, gabapentin is a reasonable suspect.

Weight gain is more common than many patients expect. A narrative review found that it can affect up to about a quarter of people taking the drug, driven largely by changes in gut function and fluid retention rather than a direct metabolic effect.⁴ The gain tends to be gradual, which means it can sneak up on you over months. Some of it is water weight from edema, and some reflects increased appetite. If weight management matters to you, tracking your intake early on can help you separate drug-related changes from lifestyle drift.

Cognitive Fog, Mood Changes, and the Suicide Question

Beyond simple drowsiness, gabapentin can produce a more persistent mental haze that patients describe as “brain fog,” trouble concentrating, or a feeling of being a step behind. A large database study in Taiwan found a significant link between cumulative gabapentin or pregabalin exposure and the risk of dementia, with people under 50 and those on higher cumulative doses showing more susceptibility.⁵ That does not mean gabapentin causes dementia in everyone, but it is a signal that long-term use at any dose deserves attention, especially in younger adults who may be on the drug for years.

The mood-related side effects are where the picture gets complicated. The FDA’s class-wide warning on antiepileptic drugs and suicidality put gabapentin under a cloud. Individual case reports describe patients developing depression, aggression, and suicidal thoughts after starting gabapentin, with symptoms resolving once the drug was stopped.⁶ These cases are real and alarming, but they tell you about the worst-case scenario, not the average experience.

Population-level data paints a more nuanced picture. A large Swedish cohort study compared periods when the same individuals were on gabapentinoids versus off them. The combined gabapentinoid class (gabapentin plus pregabalin) showed a roughly 26 percent increase in the hazard of suicidal behavior. But when the researchers separated the two drugs, the risk was driven almost entirely by pregabalin. Gabapentin alone showed no statistically significant association with suicidal behavior, overdoses, or head injuries, and it was actually linked to a reduction in road traffic incidents and arrests for violent crime.⁷ A separate study in the United States found no overall increase in suicide attempt rates after gabapentin was prescribed, and actually saw significant reductions in attempt rates among people with bipolar disorder and major depression.⁸

The takeaway is not that gabapentin is risk-free for mood, but that the suicide signal appears weaker for gabapentin specifically than for its cousin pregabalin. Still, personality changes and worsening depression can happen to individual people and should be reported to a prescriber immediately.

Respiratory Risks and COPD

One of the more serious and under-discussed risks with gabapentin involves breathing. When gabapentin is combined with opioids, the risk of respiratory depression goes up. A study in the Medicare population found that among older adults with spine conditions, those taking gabapentin plus opioids had a 5 percent rate of respiratory events, compared with about 4.2 percent in a matched group taking a different non-opioid pain medication alongside their opioids. After adjustment, the gabapentin-opioid combination carried a statistically significant increase in respiratory event risk.⁹ A separate hospital-based study confirmed that concomitant gabapentinoid and opioid use was associated with increased opioid-related overdose risk in inpatients.¹⁰

If you have chronic obstructive pulmonary disease (COPD), the concern extends beyond opioid combinations. Multiple population-level studies have found that gabapentinoid use is associated with a meaningfully increased risk of severe COPD flare-ups. One large cohort study reported an overall hazard ratio of about 1.39, meaning roughly a 39 percent increased risk of severe exacerbation compared with non-use, and the finding held regardless of whether the drug was prescribed for epilepsy, nerve pain, or other chronic pain.¹¹ A second population study found a similar magnitude of risk, with a hazard ratio of about 1.43 overall.¹² A third study, using a different comparator approach, concluded that gabapentinoids may increase exacerbation risk compared with other central nervous system-active pain medications, suggesting the effect is not just a generic feature of sedating drugs.¹³

The mechanism likely involves gabapentin’s sedating effect on the brainstem’s respiratory drive and possibly its impact on the muscles involved in breathing. If you have COPD or another condition that already compromises your lung function, this risk is worth a direct conversation with your doctor before starting gabapentin at any dose.

Why Kidney Function Changes Everything

Gabapentin is one of those drugs that the kidneys handle almost entirely. It is not broken down by the liver; it passes through you largely unchanged and gets filtered out by the kidneys. This means that if your kidneys are not working well, the drug builds up to higher levels in your blood than it would in someone with normal kidney function, and side effects can escalate from annoying to dangerous.

A study examining gabapentin toxicity in patients with chronic kidney disease found that people with moderate kidney impairment had higher blood levels of the drug, and those with severe impairment had dramatically elevated levels, sometimes more than ten times what was seen in people with normal kidney function. Toxicity occurred exclusively in the moderate and severe impairment groups, with over three-quarters of those with severe impairment developing toxic effects. Older individuals with multiple other health conditions were overrepresented among those who developed toxicity.¹⁴ The word “preventable” in that paper’s title is pointed: these cases happen because doses are not adjusted for kidney function, something that is straightforward to do but gets overlooked.

The practical implication is that a 300 mg dose in someone with healthy kidneys is not the same pharmacological event as 300 mg in someone whose kidneys are struggling. If you are over 65 or have any known kidney issues, your prescriber should be checking your kidney function and adjusting the dose downward accordingly. Symptoms of gabapentin accumulation include extreme drowsiness, confusion, slurred speech, and in severe cases, unresponsiveness.

Why 300 mg Is Not the Same for Everyone

Part of what makes gabapentin’s side-effect profile tricky is that the drug has saturable absorption. It gets into your bloodstream through a specific amino acid transport system in the upper small intestine, and that transport system has a ceiling. At low doses, a high proportion of what you swallow gets absorbed. As doses climb, a smaller percentage makes it through, which is one reason the drug is considered relatively forgiving at higher doses in terms of overdose risk.¹⁵ But this also means that 300 mg is actually the dose range where absorption is most efficient, so you are getting a proportionally larger share of what you take compared with someone on 1,200 mg three times a day.

This absorption quirk also means that taking gabapentin with food, particularly fatty food, can increase how much gets absorbed. And because the transport system is located in a specific segment of the gut, anything that speeds intestinal transit (diarrhea, certain surgeries, gut motility disorders) can reduce absorption unpredictably. The upshot: the same 300 mg capsule delivers a somewhat different internal dose depending on your gut.

Withdrawal Is Real, Even at Low Doses

One of the more underappreciated facts about gabapentin is that stopping abruptly can trigger withdrawal symptoms, and this can happen even after relatively short courses. A documented case of gabapentin withdrawal involved a patient whose symptoms began the day after stopping the drug and worsened over the next ten days, progressing to severe mental status changes, chest pain, and high blood pressure. Restarting gabapentin resolved the symptoms within a day or two.¹⁶ The fact that this patient was being tapered, not stopped cold turkey, underscores that even gradual reductions can provoke withdrawal in some individuals.

A systematic review of gabapentin misuse and abuse confirmed that the drug produces tolerance, physical dependence, and withdrawal effects. The review also found that gabapentin is most often misused in combination with other substances, especially opioids, benzodiazepines, and alcohol, and that people with a history of substance use disorders are at particular risk for misusing it.¹⁷ Several states now classify gabapentin as a controlled substance for this reason. If you have been taking it regularly for more than a few weeks, taper under medical guidance rather than stopping on your own.

Rare but Serious Allergic Reactions

DRESS syndrome, short for drug rash with eosinophilia and systemic symptoms, is a severe hypersensitivity reaction that can occur with gabapentin. It typically appears two to six weeks after starting the drug and involves a spreading rash, fever, swollen lymph nodes, and organ involvement, particularly the liver. The mortality rate for DRESS syndrome is around 10 percent, making it a genuine medical emergency.¹⁸ Case reports have documented it occurring with gabapentin after about four weeks of use, with patients showing liver enzyme elevations, high eosinophil counts, and widespread rash that required hospitalization and high-dose steroids.¹⁹

DRESS is rare, and most people taking gabapentin will never encounter it. But because it has a delayed onset, patients sometimes do not connect a new rash and fever with a medication they have been tolerating for weeks. Any combination of spreading rash, fever, and feeling generally unwell in the first couple of months of gabapentin use warrants urgent medical evaluation.

Gabapentin During Pregnancy

For pregnant individuals, the data on gabapentin is still evolving and somewhat reassuring on some fronts, less so on others. A cohort study with an accompanying meta-analysis found that first-trimester gabapentin exposure was not significantly associated with an increased risk of overall birth defects, heart defects, or cleft lip and palate after adjusting for confounders. However, the meta-analysis of raw, unadjusted results did show elevated risks for major defects and heart defects, suggesting that factors like the underlying condition being treated or other medication use may explain part of the signal.²⁰

What did show a clear association was a roughly doubled risk of the baby being admitted to the neonatal intensive care unit when the mother used gabapentin during any trimester. That increased NICU admission rate appears to be partly driven by neonatal withdrawal. Case reports have described newborns exposed to gabapentin in utero showing distinctive withdrawal behaviors, including tongue thrusting, wandering eye movements, back arching, and continuous limb movements.²¹ A separate case report documented similar neonatal withdrawal signs after prolonged in utero exposure.²² The risk appears to be highest when gabapentin is combined with opioids, which is unfortunately a common clinical scenario in patients with chronic pain.

How Gabapentin Actually Works on Your Nerves

Understanding the mechanism helps explain why the side effects cut across so many different body systems. Gabapentin binds to a specific protein called the alpha-2-delta subunit that sits on the surface of voltage-gated calcium channels in nerve cells. These channels control how much calcium flows into nerve endings, which in turn determines how many chemical signals those nerves release. By binding to this subunit, gabapentin gradually reduces the trafficking of these channels to the cell surface, meaning fewer channels end up where they can fire.¹ Molecular and genetic studies strongly support this as the sole target responsible for gabapentin’s pain-relieving effects.²³

The key word is “chronically.” Research has shown that gabapentin does not produce meaningful effects when applied to nerve cells briefly. The inhibition of calcium currents only emerges with sustained exposure, which is why the drug takes days to reach full effect and why stopping abruptly can cause rebound problems.¹ The selectivity of this target is actually good news in some respects: gabapentin does not interact with GABA receptors (despite its misleading name), does not bind to opioid receptors, and is not processed by liver enzymes that handle most other drugs. That last point means it has few direct drug-drug interactions at the metabolic level, though its additive sedative effects when combined with opioids, benzodiazepines, or alcohol are very real and clinically dangerous.

The calcium channel subunit that gabapentin targets is found throughout the central and peripheral nervous system, not just in pain-sensing nerves. This is why a drug aimed at nerve pain also makes you drowsy (it dampens signaling in the brain), dizzy (it affects balance circuits), and foggy (it slows cortical processing). The side effects are not bugs in the system; they are the main effect showing up in places you did not want it.